Cibc Private Wealth Group, LLC Gilead Sciences, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
 - Q1 2025
 
A detailed history of Cibc Private Wealth Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 45,469 shares of GILD stock, worth $5.55 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
45,469
              Previous 45,205
              
        
           0.58%
        
      
          
        Holding current value
$5.55 Million
            Previous $4.18 Million
            
        
           22.01%
        
      
          
        % of portfolio
0.01%
            Previous 0.01%
          
        Shares
	  37 transactions
	
  Others Institutions Holding GILD
# of Institutions
2,352Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M- 
    
      Black Rock Inc. New York, NY121MShares$14.7 Billion0.19% of portfolio
 - 
    
      Vanguard Group Inc Valley Forge, PA119MShares$14.6 Billion0.22% of portfolio
 - 
    
      State Street Corp Boston, MA59.2MShares$7.22 Billion0.25% of portfolio
 - 
    
      Capital World Investors Los Angeles, CA46.3MShares$5.65 Billion0.78% of portfolio
 - 
    
      Wellington Management Group LLP Boston, MA37.5MShares$4.58 Billion0.79% of portfolio
 
About GILEAD SCIENCES, INC.
- Ticker GILD
 - Exchange NASDAQ
 - Sector Healthcare
 - Industry Drug Manufacturers—General
 - Shares Outstandng 1,253,369,984
 - Market Cap $153B
 - Description
 - Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...